Kurt A. Gustafson

Vice President, Finance, Halozyme Therapeutics.

Companies

OmniAb, Inc.Chief financial officer Nov 3, 2022 to now¹
Xencor IncBoard member Jul 16, 2014 to now²
Spectrum PharmaceuticalsChief financial officer Jun 5, 2013 to Mar 16, 2022³
Niagen Bioscience, Inc.Board member Oct 27, 2016 to Jun 22, 2021⁴
Halozyme TherapeuticsChief financial officer Feb 8, 2010 to Feb 6, 2013⁵
Halozyme TherapeuticsVice President, Finance Apr 23, 2009 to Apr 23, 2009⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROmniAb, Inc., Chief financial officer
2
SEC EDGARXencor Inc, Board member
3
SEC EDGARSpectrum Pharmaceuticals, Chief financial officer
4
SEC EDGARNiagen Bioscience, Inc., Board member
5
SEC EDGARHalozyme Therapeutics, Chief financial officer
6
SEC EDGARHalozyme Therapeutics, Vice President, Finance